Die Behandlung mit mesenchymalen Stammzellen reduziert oxidativen Stress bei chronischen Lebererkrankungen
Mesenchymale Stammzelle (MSC) therapy shows promise in mitigating oxidative stress, a key driver of chronic liver disease progression. Our analysis reveals MSC treatment significantly reduces oxidative markers, suggesting a novel therapeutic avenue. Learn more about the findings and implications.



